添加微信 添加微信
添加微信
首页: 全球医药政策
  • TRIO

    We are TRIO, a not-for-profit academic clinical research organization (CRO). We are academic leaders in our field and share your goal to find the shortest path to saving lives. With a worldwide network of over 700 cancer centres, we can deliver accurate clinical trial results efficiently and on time. Our mission is focused on results that help cancer patients live longer. ...

  • Synteract

    As you consider which CRO to work with, it is natural to ask “Why Synteract”? Why should you choose to trust in Synteract as your CRO? What makes a job candidate make a decision to further their career by joining us? What makes our employees stay? What do you need that our teams can deliver best? At the end of the day, for us and the people that work for us, it is all about improving the quali ...

  • Syneos Health

    Syneos Health conducts clinical studies for pharmaceutical companies in virtually all therapeutic areas. These generally aim to assess the extent of the body’s absorption and elimination of a drug to determine its safety for use in humans. ...

  • Solvias

    The name Solvias is derived from the Latin terms ‘solutio’ and ‘via’ – it is our promise to explore new ways to find solutions that fulfill your requirements. Building on a profound foundation of experience from a large multinational pharmaceutical company Solvias was formed in 1999 as a management buy-out. The international expansion was accelerated in 2013 with the acquisition of Confa ...

  • Simbec-Orion

    Simbec-Orion was created in 2014 by the merger of two very experienced CROs: Simbec Research, a specialist CRO in Early Stage Clinical Development and Orion Clinical, the specialist CRO in Late Stage Clinical Development to create an international, full service, boutique CRO. We offer specialist expertise in oncology, rare & orphan diseases, respiratory, dermatology and infectious vaccines & disea ...

  • PPD

    PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 48 countries and more than 20,000 professionals worldwide, PPD applies innovative technologies, therapeutic ex ...

  • Popsicube-Fovea

    Popsicube-Fovea is not only a CRO. We act in several collaborative projects in the area of the future of health care, like personnalized and predictive medecine, and artificial intelligence where our combined expertises in clinical trials and new technologies have great applications: Clinical Services,data Management, biostatistics,innovative data collection tools, secured gateway, biosensor,tailo ...

  • Physiogenex

    Physiogenex is an expert preclinical CRO for metabolic disorders based in Toulouse, France. For more than 15 years, we have been developing and using our expertise in metabolic diseases to provide reliable preclinical studies for the treatment of such pathologies. We develop innovative models for all metabolic diseases and their complications, as well as a wide range of tests to demonstrate the ef ...

  • Pharmaspecific

    Pharmaspecific is a Contract Research Organization (CRO) and a Site mangement organization (SMO) founded in 2010 to meet the needs of the pharmaceutical and medical device industries. As a human-sized company, it puts people at the center of its relationships and development. Certified with the ISO 9001:2015 standard for several years, Pharmaspecific presents its Charter of Excellence which makes ...

  • Pelvipharm

    Founded in 1999, PELVIPHARM is a spin-off from the University of Versailles-Saint-Quentin-en-Yvelines (France) relying on multi-disciplinary talents (medical doctor, pharmaco-economist, veterinarian, pharmacists and PhDs) who deliver both high quality academic standards and reliable contract research services : Preclinical studies based on validated efficacy models including delivery of protocol d ...

频道栏目

最新文章

热门文章